SBC Medical Group Holdings Acquires Majority Stake in Waqoo
SBC Medical Group Holdings has finalized its acquisition of Waqoo, Inc., a company specializing in regenerative medicine technologies listed on the Tokyo Stock Exchange Growth Market. The tender offer, which began on November 14, 2025 and concluded on December 12, 2025, was conducted at JPY 1,900 per share for a total of 575,052 common shares. Settlement is scheduled to begin on December 19, 2025. Additionally, Yoshiyuki Aikawa, the largest shareholder of Waqoo, Inc., will transfer his remaining shares to SBC Medical through an off-market transaction, also effective December 19. As a result, SBC Medical's ownership in Waqoo, Inc. will exceed 50%, making it the new parent company and largest shareholder. The acquisition is intended to strengthen SBC Medical's service offerings and R&D capabilities in the healthcare sector.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SBC Medical Group Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-318331), on December 15, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.